查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830750

2025年全球器官移植市場報告

Cross-Species Organ Transplantation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，異種移植市場呈現強勁成長勢頭，從2024年的139.8億美元成長至2025年的152億美元，複合年成長率為8.7%。這段時期的成長歸因於廣泛的動物模型實驗、新興的生物倫理爭論、慢性病盛行率的上升、豬-靈長類動物移植實驗以及終末期器官衰竭導致的高死亡率。

異種移植市場規模預計在未來幾年強勁成長，到2029年將達到209.5億美元，複合年成長率為8.3%。預測期內的成長可歸因於對可移植器官需求的不斷成長、再生醫學投資的不斷增加、全球慢性腎臟病和肝臟疾病負擔的加重、患者對移植可及性的倡導以及人類捐贈者的日益減少。這段時期的主要趨勢包括基因編輯豬器官生產、與人體相容的基因組工程、人工智慧在器官匹配中的整合、血管3D生物列印、機器灌注和器官保存技術的進步，以及用於免疫抑制的奈米級藥物傳輸系統。

異種器官移植，通常稱為異種移植，是指將一個物種的活細胞、組織或整個器官移植到另一個物種，通常是從動物移植到人類。異種移植的主要目的是緩解需要移植的患者員工捐贈者短缺的問題。

異種移植的主要產品類型包括器官保存液、移植診斷產品和異種移植產品。器官保存液是特殊配製的液體，用於在運輸過程中和移植前維持體外器官的活力。這些產品用於各種手術，包括腎臟、心臟、肝臟和肺移植，最終用戶包括移植中心、醫院和其他醫療機構。

2025年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了嚴重影響，特別是對關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了壓力，導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅阻礙了基本藥品和醫療設備的生產，造成了供應鏈瓶頸。作為應對措施，該行業正在籌資策略多樣化，盡可能促進本地生產，並倡導對緊急醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供異種移植市場統計數據，例如全球市場規模、區域佔有率、異種移植市場佔有率的競爭對手、詳細的異種移植細分市場、市場趨勢和商業機會，以及在異種移植行業取得成功所需的數據。異種移植市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊。

器官衰竭發病率的上升，尤其是創傷相關的多重器官衰竭，預計將在未來幾年推動異種移植市場的成長。異種移植，也稱為異種移植，涉及將器官從動物移植到人類，以解決捐贈器官的嚴重短缺問題。基因工程的廣泛使用透過改造動物器官來減少免疫排斥並提高與人類接受者的相容性，在這一市場中發揮關鍵作用。例如，到 2023 年 7 月，美國基因與細胞治療學會報告稱，處於 2 期臨床試驗的基因療法從第一季的 247 個增加到第二季的 260 個，凸顯了基因工程應用的快速擴展。這一趨勢正在推動能夠解決人體器官短缺問題的異種移植解決方案的開發。

異種移植市場的公司擴大建立策略夥伴關係，以加速臨床試驗和監管核准。策略夥伴關係關係使公司能夠利用彼此的專業知識和資源，從而在無需全面合併的情況下激發創新。例如，2025年2月，美國生物技術公司United Therapeutics與eGenesis合作，啟動了FDA核准的基因改造豬腎移植人體臨床試驗。這些臨床試驗旨在為腎衰竭患者提供永續的替代方案，並解決全球捐贈器官短缺的問題。

2023年12月，聯合治療公司（United Therapeutics Corporation）收購了Miromatrix Medical, Inc.，進一步增強了其異種移植能力。 Miromatrix Medical, Inc.是一家專注於透過去細胞和再細胞化技術進行生物工程器官開發的美國公司。此次收購增強了聯合治療公司開發結合基因和生物工程方法的先進異種移植解決方案的能力，從而擴大了可移植器官的可用性。

異種器官移植市場由提供臨床前和臨床異種移植服務、器官和組織配型、移植後護理和監測以及再生和生物工程解決方案等服務的營業單位所獲得的收益構成。市場價值包括服務供應商銷售的或包含在其服務產品中的任何相關商品的價值。異種器官移植市場還包括免疫抑制劑、活組織以及器官支架或基質的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球異種移植：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球異種移植市場：成長率分析
  • 全球異種器官移植市場表現：規模與成長，2019-2024
  • 全球異種器官移植市場預測：規模與成長，2024-2029年，2034年
  • 全球異種移植：總潛在市場（TAM）

第6章 市場細分

  • 全球異種移植市場（依產品類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 器官保存解決方案
  • 移植診斷
  • 芝諾產品
  • 其他產品類型
  • 全球異種移植市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 腎
  • 心
  • 肝
  • 肺
  • 其他用途
  • 全球異種移植市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 移植中心
  • 醫院
  • 其他最終用戶
  • 全球異種移植市場：依器官保存解決方案細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 低溫機灌注 (HMP) 解決方案
  • 常溫機械灌注（NMP）溶液
  • 靜態冷藏保管（SCS）解決方案
  • 氧合灌注液
  • 全球異種器官移植市場：依移植診斷（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 組織分型
  • 交叉配對試驗
  • 分子分型（DNA檢測）
  • 免疫監測試驗
  • 全球異種移植市場：依產品類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 基因改造捐贈器官
  • 去細胞器官支架
  • 異源細胞治療
  • 異種移植的免疫抑制治療
  • 全球異種移植市場：按類型細分、按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 器官運輸裝置
  • 器官提取和保存設備
  • 移植手術器械
  • 移植後監測裝置

第7章 區域和國家分析

  • 全球異種器官移植市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球異種器官移植市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 異種移植市場：競爭格局
  • 異種移植市場：公司簡介
    • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-la Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Optipharm Co Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Astellas Pharma Inc.
  • United Therapeutics Corporation
  • TransMedics Group Inc.
  • Artivion Inc.
  • eGenesis Inc.
  • Organ Recovery Systems Inc.
  • OrganOX Ltd
  • Paragonix Technologies Inc.
  • Qihan Biotech
  • PorMedTec Co.
  • XenoTheraputics Inc.
  • Makana Therapeutics Inc.
  • Preservation Solutions Inc.
  • Nzeno Ltd
  • Infigen Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年異種移植市場：提供新機會的國家
  • 2029年異種移植市場：細分領域帶來新機會
  • 異種移植市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37738

Cross-species organ transplantation, commonly referred to as xenotransplantation, involves transferring living cells, tissues, or whole organs from one species to another, most often from animals to humans. The primary aim of xenotransplantation is to alleviate the shortage of human donor organs for patients requiring transplants.

The main product types in cross-species organ transplantation include organ preservation solutions, transplant diagnostics, xeno products, and others. Organ preservation solutions are specially formulated liquids designed to maintain organ viability outside the body during transport and prior to transplantation. These products are applied in a variety of procedures, including kidney, heart, liver, and lung transplants, and are utilized by end users such as transplant centers, hospitals, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cross-species organ transplantation market research report is one of a series of new reports from The Business Research Company that provides cross-species organ transplantation market statistics, including cross-species organ transplantation industry global market size, regional shares, competitors with a cross-species organ transplantation market share, detailed cross-species organ transplantation market segments, market trends and opportunities, and any further data you may need to thrive in the cross-species organ transplantation industry. The cross-species organ transplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cross-species organ transplantation market size has grown strongly in recent years. It will grow from $13.98 billion in 2024 to $15.20 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be attributed to extensive animal model experimentation, the emergence of bioethical debates, the increasing prevalence of chronic diseases, experimental pig-to-primate transplants, and high mortality rates from end-stage organ failure.

The cross-species organ transplantation market size is expected to see strong growth in the next few years. It will grow to $20.95 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising demand for transplantable organs, increasing investments in regenerative medicine, the global burden of chronic kidney and liver diseases, patient advocacy for transplant access, and the declining availability of human donors. Major trends during this period include the production of gene-edited pig organs, human-compatible genome engineering, integration of artificial intelligence in organ matching, 3D bioprinting of vascular structures, advancements in machine perfusion and organ preservation technologies, and nanoscale drug delivery systems for immunosuppression.

The rising incidence of organ failure, particularly trauma-related multiple organ failure, is expected to drive the growth of the cross-species organ transplantation market in the coming years. Cross-species organ transplantation, also known as xenotransplantation, involves transplanting organs from animals into humans to address critical shortages of donor organs. The growing adoption of genetic engineering plays a pivotal role in this market by enabling the modification of animal organs to reduce immune rejection, making them more compatible for human recipients. For example, by July 2023, the American Society of Gene & Cell Therapy reported an increase in gene therapies in Phase II clinical trials from 247 in the first quarter to 260 in the second quarter, highlighting the rapid expansion of genetic engineering applications. This trend supports the development of xenotransplantation solutions capable of addressing the shortage of human organs.

Companies in the cross-species organ transplantation market are increasingly forming strategic partnerships to accelerate clinical trials and regulatory approvals. Strategic partnerships allow organizations to leverage each other's expertise and resources, fostering innovation without requiring full mergers. For instance, in February 2025, United Therapeutics, a US-based biotechnology company, partnered with eGenesis to begin FDA-approved clinical trials for genetically modified pig kidney transplants in humans. These trials aim to provide a sustainable alternative for patients with kidney failure, addressing the global donor organ shortage.

In December 2023, United Therapeutics Corporation further strengthened its xenotransplantation capabilities by acquiring Miromatrix Medical Inc., a US-based company specializing in bioengineered organs through decellularization and recellularization techniques. This acquisition enhances United Therapeutics' ability to develop advanced cross-species organ transplantation solutions, combining genetic engineering and bioengineering approaches to expand the availability of transplantable organs.

Major players in the cross-species organ transplantation market are Pfizer Inc, F. Hoffmann-la Roche Ltd, Sanofi SA, Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc.

North America was the largest region in the cross-species organ transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cross-species organ transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cross-species organ transplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cross-species organ transplantation market consists of revenues earned by entities by providing services such as preclinical and clinical xenotransplantation services, organ and tissue matching, post-transplant care and monitoring, and regenerative and bioengineered solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The cross-species organ transplantation market also includes sales of immunosuppressive drugs, bioengineered tissues, and organ scaffolds or matrices. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cross-Species Organ Transplantation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cross-species organ transplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cross-species organ transplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cross-species organ transplantation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Organ Preservation Solution; Transplant Diagnostics; Xeno Products; Other Product Types
  • 2) By Application: Kidney; Heart; Liver; Lung; Other Applications
  • 3) By End-User: Transplant Centers; Hospitals; Other End-Users
  • Subsegments:
  • 1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions; Normothermic Machine Perfusion (NMP) Solutions; Static Cold Storage (SCS) Solutions; Oxygenated Perfusion Solutions
  • 2) By Transplant Diagnostics: Histocompatibility Testing; Crossmatching Tests; Molecular Typing (DNA-based Testing); Immunological Monitoring Assays
  • 3) By Xeno Products: Genetically Engineered Donor Organs; Decellularized Organ Scaffolds; Xenogeneic Cellular Therapies; Immunosuppressive Regimens For Xenotransplants
  • 4) By Other Product Types: Organ Transport Devices; Organ Recovery and Preservation Equipment; Surgical Instruments For Transplantation; Post-Transplant Monitoring Devices
  • Companies Mentioned: Pfizer Inc; F. Hoffmann-la Roche Ltd; Sanofi SA; Novartis AG; Optipharm Co Ltd; Astellas Pharma Inc.; United Therapeutics Corporation; TransMedics Group Inc.; Artivion Inc.; eGenesis Inc.; Organ Recovery Systems Inc.; OrganOX Ltd; Paragonix Technologies Inc.; Qihan Biotech; PorMedTec Co.; XenoTheraputics Inc.; Makana Therapeutics Inc.; Preservation Solutions Inc.; Nzeno Ltd; Infigen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cross-Species Organ Transplantation Market Characteristics

3. Cross-Species Organ Transplantation Market Trends And Strategies

4. Cross-Species Organ Transplantation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cross-Species Organ Transplantation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cross-Species Organ Transplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cross-Species Organ Transplantation Market Growth Rate Analysis
  • 5.4. Global Cross-Species Organ Transplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cross-Species Organ Transplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cross-Species Organ Transplantation Total Addressable Market (TAM)

6. Cross-Species Organ Transplantation Market Segmentation

  • 6.1. Global Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organ Preservation Solution
  • Transplant Diagnotics
  • Xeno Products
  • Other Product Types
  • 6.2. Global Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kidney
  • Heart
  • Liver
  • Lung
  • Other Applications
  • 6.3. Global Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transplant Centers
  • Hospitals
  • Other End-Users
  • 6.4. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Organ Preservation Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypothermic Machine Perfusion (HMP) Solutions
  • Normothermic Machine Perfusion (NMP) Solutions
  • Static Cold Storage (SCS) Solutions
  • Oxygenated Perfusion Solutions
  • 6.5. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Transplant Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Histocompatibility Testing
  • Crossmatching Tests
  • Molecular Typing (DNA-based Testing)
  • Immunological Monitoring Assays
  • 6.6. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Xeno Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetically Engineered Donor Organs
  • Decellularized Organ Scaffolds
  • Xenogeneic Cellular Therapies
  • Immunosuppressive Regimens For Xenotransplants
  • 6.7. Global Cross-Species Organ Transplantation Market, Sub-Segmentation Of Other Types, By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organ Transport Devices
  • Organ Recovery And Preservation Equipment
  • Surgical Instruments For Transplantation
  • Post-Transplant Monitoring Devices

7. Cross-Species Organ Transplantation Market Regional And Country Analysis

  • 7.1. Global Cross-Species Organ Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cross-Species Organ Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cross-Species Organ Transplantation Market

  • 8.1. Asia-Pacific Cross-Species Organ Transplantation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cross-Species Organ Transplantation Market

  • 9.1. China Cross-Species Organ Transplantation Market Overview
  • 9.2. China Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cross-Species Organ Transplantation Market

  • 10.1. India Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cross-Species Organ Transplantation Market

  • 11.1. Japan Cross-Species Organ Transplantation Market Overview
  • 11.2. Japan Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cross-Species Organ Transplantation Market

  • 12.1. Australia Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cross-Species Organ Transplantation Market

  • 13.1. Indonesia Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cross-Species Organ Transplantation Market

  • 14.1. South Korea Cross-Species Organ Transplantation Market Overview
  • 14.2. South Korea Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cross-Species Organ Transplantation Market

  • 15.1. Western Europe Cross-Species Organ Transplantation Market Overview
  • 15.2. Western Europe Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cross-Species Organ Transplantation Market

  • 16.1. UK Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cross-Species Organ Transplantation Market

  • 17.1. Germany Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cross-Species Organ Transplantation Market

  • 18.1. France Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cross-Species Organ Transplantation Market

  • 19.1. Italy Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cross-Species Organ Transplantation Market

  • 20.1. Spain Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cross-Species Organ Transplantation Market

  • 21.1. Eastern Europe Cross-Species Organ Transplantation Market Overview
  • 21.2. Eastern Europe Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cross-Species Organ Transplantation Market

  • 22.1. Russia Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cross-Species Organ Transplantation Market

  • 23.1. North America Cross-Species Organ Transplantation Market Overview
  • 23.2. North America Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cross-Species Organ Transplantation Market

  • 24.1. USA Cross-Species Organ Transplantation Market Overview
  • 24.2. USA Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cross-Species Organ Transplantation Market

  • 25.1. Canada Cross-Species Organ Transplantation Market Overview
  • 25.2. Canada Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cross-Species Organ Transplantation Market

  • 26.1. South America Cross-Species Organ Transplantation Market Overview
  • 26.2. South America Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cross-Species Organ Transplantation Market

  • 27.1. Brazil Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cross-Species Organ Transplantation Market

  • 28.1. Middle East Cross-Species Organ Transplantation Market Overview
  • 28.2. Middle East Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cross-Species Organ Transplantation Market

  • 29.1. Africa Cross-Species Organ Transplantation Market Overview
  • 29.2. Africa Cross-Species Organ Transplantation Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cross-Species Organ Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cross-Species Organ Transplantation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cross-Species Organ Transplantation Market Competitive Landscape And Company Profiles

  • 30.1. Cross-Species Organ Transplantation Market Competitive Landscape
  • 30.2. Cross-Species Organ Transplantation Market Company Profiles
    • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-la Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Optipharm Co Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Cross-Species Organ Transplantation Market Other Major And Innovative Companies

  • 31.1. Astellas Pharma Inc.
  • 31.2. United Therapeutics Corporation
  • 31.3. TransMedics Group Inc.
  • 31.4. Artivion Inc.
  • 31.5. eGenesis Inc.
  • 31.6. Organ Recovery Systems Inc.
  • 31.7. OrganOX Ltd
  • 31.8. Paragonix Technologies Inc.
  • 31.9. Qihan Biotech
  • 31.10. PorMedTec Co.
  • 31.11. XenoTheraputics Inc.
  • 31.12. Makana Therapeutics Inc.
  • 31.13. Preservation Solutions Inc.
  • 31.14. Nzeno Ltd
  • 31.15. Infigen Inc.

32. Global Cross-Species Organ Transplantation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cross-Species Organ Transplantation Market

34. Recent Developments In The Cross-Species Organ Transplantation Market

35. Cross-Species Organ Transplantation Market High Potential Countries, Segments and Strategies

  • 35.1 Cross-Species Organ Transplantation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cross-Species Organ Transplantation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cross-Species Organ Transplantation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer